What is Microprobes?
Microprobes for Life Science is a key player in the field of electrophysiology, providing advanced microelectrodes and microelectrode arrays essential for neural research. Their product portfolio supports both in vivo and in vitro studies, encompassing metal microelectrodes, optogenetic arrays, and sophisticated neural interfaces. These tools are critical for chronic and acute experiments, serving a global base of scientists engaged in advanced neural recording and stimulation technologies. The company's commitment to innovation positions it as a trusted partner for researchers requiring high-quality neural interface solutions.
How much funding has Microprobes raised?
Microprobes has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Microprobes
PPP
Public-Private Partnership
What's next for Microprobes?
The substantial backing indicated by $150K suggests Microprobes is in a significant growth phase, likely focusing on scaling its manufacturing capabilities and expanding its research and development efforts. The recent strategic investment, $150K, points towards a potential expansion into new markets or the development of next-generation neural interface technologies. This capital infusion is expected to accelerate the company's mission to empower neuroscientists with cutting-edge tools for understanding the brain.
See full Microprobes company page
